Literature DB >> 7157414

Inhibition of mitochondrial aldehyde dehydrogenase by malondialdehyde.

J J Hjelle, J H Grubbs, D R Petersen.   

Abstract

Rat liver mitochondria contain an aldehyde dehydrogenase (ALDH, EC 1.2.1.3) with a low Km for acetaldehyde (2 microM) which is susceptible to inhibition by a variety of agents including p-chloromercuribenzoate and arsenite. This low Km ALDH isozyme has been shown to be decreased in activity following CCl4 treatment in vivo and by lipid peroxidation in vitro. Malondialdehyde, the most studied product of lipid peroxidation, was investigated for possible inhibitory effects on the low Km ALDH for rat liver mitochondria. Malondialdehyde was found to be a potent inhibitor of the enzyme. The enzyme was equally sensitive to inhibition when intact mitochondrial preparations were compared with disrupted mitochondria. The extent of enzyme inhibition was dependent on malondialdehyde concentration and time of incubation. High concentrations of malondialdehyde completely inhibited low Km mitochondrial ALDH activity. Malondialdehyde was found to inhibit the low Km ALDH irreversibly. The rate of ALDH inactivation exhibited two phases, one a rapid rate phase (5-15 s) and a second slower rate phase, both of which showed rates which were dependent on malondialdehyde concentration. These data show that malondialdehyde is a potent, high affinity, irreversible inhibitor of the low Km ALDH of rat liver mitochondria. This ALDH isozyme is considered to be the most important enzyme in acetaldehyde metabolism. Malondialdehyde inhibition of the low Km ALDH may be important since both ethanol and acetaldehyde are thought to stimulate hepatic lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7157414     DOI: 10.1016/0378-4274(82)90007-8

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease.

Authors:  Yunden Jinsmaa; Virginia R Florang; Jennifer N Rees; Lydia M Mexas; Laurie L Eckert; Erin M G Allen; David G Anderson; Jonathan A Doorn
Journal:  Chem Biol Interact       Date:  2011-01-13       Impact factor: 5.192

2.  Regulation of human mitochondrial aldehyde dehydrogenase (ALDH-2) activity by electrophiles in vitro.

Authors:  Matthias Oelze; Maike Knorr; Richard Schell; Jens Kamuf; Andrea Pautz; Julia Art; Philip Wenzel; Thomas Münzel; Hartmut Kleinert; Andreas Daiber
Journal:  J Biol Chem       Date:  2011-01-20       Impact factor: 5.157

3.  Aldehyde dehydrogenase 7A1 (ALDH7A1) attenuates reactive aldehyde and oxidative stress induced cytotoxicity.

Authors:  Chad Brocker; Miriam Cantore; Paola Failli; Vasilis Vasiliou
Journal:  Chem Biol Interact       Date:  2011-02-19       Impact factor: 5.192

4.  Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.

Authors:  Yunden Jinsmaa; Virginia R Florang; Jennifer N Rees; David G Anderson; Stefan Strack; Jonathan A Doorn
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.